Now Recruiting in the US

Quay Pharma has been building its business in the US over the last five years. We now have a strong client base on the Eastern seaboard, which is developing further across the US.

To locally support our growing US customers, we have significantly extended our presence in the United States by securing a 55,000 sq ft facility for pharmaceutical development and clinical manufacturing in Hudson, NH.

The new facility will be initially fitted out with analytical, formulation, and pilot labs. The first GMP manufacturing suites will be operating in early Q3 2021. The site will create over 100 jobs within three years of being operational.

This exciting new phase in Quay’s growth now means there is a range of inspiring career opportunities.